Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aclaris Therapeutics Inc | 2.930% | 6.362% | 8.821% | -86.817% | 21.421% | -94.813% | - |
| Heron Therapeutics Inc. | 0.220% | 8.562% | -1.986% | 5.496% | 76.051% | -81.324% | - |
| Pacific Biosciences of California Inc. | 6.320% | -57.893% | -62.609% | -87.032% | -86.042% | -95.032% | -80.224% |
| Enlivex Therapeutics Ltd. | 16.260% | -66.576% | -66.757% | -52.326% | -45.089% | -86.257% | - |
| Adaptimmune Therapeutics PLC ADR | -8.290% | -21.849% | -31.618% | -26.772% | 48.800% | -77.427% | - |
| Medigene AG | -2.160% | -13.953% | 13.846% | 2.210% | 16.352% | -52.926% | -79.957% |
| Fate Therapeutics Inc. | 0.200% | -19.835% | -27.945% | -17.945% | 39.004% | -92.709% | - |
| Cytomx Therapeutics Inc | -0.910% | -15.612% | -13.221% | 5.350% | 18.481% | -73.662% | - |